Healthcare -
Biotechnology - NASDAQ - US
$ 8.35
1.09 %
$ 81.2 M
Market Cap
-0.23
P/E
BLUE - REVENUE
Revenue BLUE - bluebird bio, Inc.
29.5 M
LAST VALUE
183.81%
2 YEAR CAGR
-11.58%
5 YEAR CAGR
3.87%
10 YEAR CAGR